ELOX

Eloxx Pharmaceuticals Inc.

Price

$16.73

return (12m)

1,520,809.09% Logo

p/e

-12.05

p/bv

2.63

DIVIDEND YIELD

0.00%

ELOX price

Eloxx Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ELOX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-17.83%

3 months

39.42%

1 year

1,520,809.09%

2 years

253,384.85%

5 years

-97.90%

10 years

-98.99%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ELOX

Valuation

P/E

-12.05

Sector 1.14

Industry -1.74

P/BV

2.63

Sector 1.86

Industry 1.35

P/Revenue (PSR)

Sector 1.56

Industry 2.25

EV/EBITDA

Sector -48.05

Industry -42.10

EV/EBIT

Sector -27.46

Industry -45.23

P/EBITDA

-12.47

Sector -32.50

Industry -22.84

P/EBIT

-12.47

Sector -43.68

Industry -27.02

P/Total Assets

1.93

Sector 0.88

Industry 0.82

P/Net Current Assets

2.63

Sector -27.11

Industry -72.49

P/Working Capital

2.63

Sector 2.78

Industry -2.12

EPS

-1.49

Sector -0.70

Industry -1.11

BVPS

6.84

Sector 4.34

Industry 2.55

Efficiency

Gross Margin

0.00%

Sector 49.36%

Industry 50.48%

EBITDA Margin

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

0.00%

Sector -19.73%

Industry -25.75%

Net Profit Margins

0.00%

Sector -24.22%

Industry -27.82%

Asset Turnover

Sector 0.13

Industry 0.06

Profitability

ROE

-21.86%

Sector -24.32%

Industry -33.33%

ROA

-16.01%

Sector -24.41%

Industry -45.73%

ROIC

-150.11%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.74

Sector 1.90

Industry 2.51

Net Debt / EBITDA

Sector -4.96

Industry -8.98

Net Debt / EBIT

Sector -3.08

Industry -37.38

Net Debt / Equity

Sector -0.45

Industry -1.16

Gross Debt / Equity

Sector -0.74

Industry -0.56

Equity/Assets

0.73

Sector 0.46

Industry 0.52

Liabilities/Assets

0.27

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-31.39%

Sector -

Industry -

Fundamentals ELOX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ELOX Eloxx Pharmaceuticals Inc.	$16.73	1,520,809.09%	0.00%	-12.05	2.63	-21.86%	0.00%
LLY Eli Lilly and Compay	$1,170.14	56.59%	0.59%	38.16	30.09	78.84%	33.53%
SNY Sanofi	$42.51	-7.25%	4.17%	3.97	0.73	18.43%	14.25%
GSK GlaxoSmithKline PLC	$50.72	30.45%	3.54%	15.39	4.35	28.24%	14.54%
CRMD CorMedix Inc.	$7.78	-30.54%	0.00%	3.22	1.31	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$24.32	-12.01%	0.00%	13.18	1.35	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.57	-14.86%	0.69%	27.59	2.49	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.65	-95.88%	0.00%	0.01	0.01	63.85%	0.00%
ISRG Intuitive Surgical Inc.	$402.09	-8.35%	0.00%	44.01	7.60	17.26%	28.62%
NVS Novartis AG	$141.28	17.16%	2.22%	20.89	6.35	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$658.52	37.91%	0.28%	34.71	4.60	13.25%	15.07%
ABT Abbott Laboratories	$103.69	-21.95%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$90.77	-0.65%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$44.92	-54.08%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$88.07	-27.98%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$221.97	-17.89%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$521.50	-20.52%	0.00%	35.48	25.07	70.67%	25.03%
HCA HCA Healthcare Inc.	$438.12	9.62%	0.70%	12.06	-29.52	-244.72%	10.07%
COHR Coherent Inc.	$310.39	184.47%	0.00%	75.62	5.36	7.09%	11.19%
DHR Danaher Corporation	$221.09	17.62%	0.68%	37.21	2.83	7.61%	15.95%
SYK Stryker Corp.	$275.09	-26.02%	1.26%	28.38	4.41	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ELOX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Eloxx Pharmaceuticals

Eloxx Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (11 people)

United States

27 years

Founded: 1999

1998

Time since IPO - 28 years

25

Employees

Eloxx Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $122.27 million, with shareholders equity totaling $46.42 million.

The company employs approximately 25 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Eloxx Pharmaceuticals Inc. reported $- in revenue, generating net income of $-10.15 million.

Key financial metrics include a P/E ratio of -12.05, a price-to-book (P/B) ratio of 2.63, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ELOX.

Market cap

$122.27 million

Net worth

$46.42 million

$46,420,000.00

Assets

$63.39 million

$63,388,000.00

Total Shares Outstanding

6.79 million

6,789,000

Average Daily Trading Volume

$51.13 Thousand

$51,126.00

Sector

Health

Industry

Pharmaceutical Products

ELOX

ELOX revenue and profits

Financial Results ELOX

DRAG THE FRAME TO SEE MORE DATA

ELOX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$87.10 17,45% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$273.74 --3,50% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$63.30 93,28% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$372.00 46,41% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.51 --5,75% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,170.14 57,64% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$438.12 7,71% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$141.28 17,26% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35